SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SciClone Pharmaceuticals (Holdings) Limited, along with Silver Pegasus Investment Limited, has effectively completed its privatization plan through a scheme of arrangement, as per the sanction by the Grand Court. The privatization resulted in the proposed withdrawal of the company’s listing. Furthermore, the company has achieved full acceptance of its Option Offer, with all outstanding share options tendered as of the closing date.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.